Yong Li

7PUBLICATIONS
9CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Oncology and carcinogenesis not elsewhere classifiedFood properties (incl. characteristics and health benefits)Humoural immunology and immunochemistryMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 01, 2026
The Potential of High-Density Lipoprotein as a Predictive Biomarker for Infliximab Efficacy in Crohn's Disease.

Keke Tang, Ziheng Peng, Duo Xu

|Nov 09, 2023
Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated.

Sai Li, Yong Li

|Oct 16, 2023
Progress and Clinical Applications of Crohn's Disease Exclusion Diet in Crohn's Disease.

Duo Xu, Ziheng Peng, Yong Li

|Mar 17, 2023
Early gastric mucosa-associated lymphoid tissue lymphoma treated by endoscopic submucosal dissection.

Yu Wu, Yong Li, Xiaowei Liu

|Apr 26, 2022
A rare cause of a bulging mass in the mid esophagus.

Sai Li, Yong Li, Liangrong Shi

|Jul 26, 2021
A random forest model predicts responses to infliximab in Crohn's disease based on clinical and serological parameters.

Yong Li, Jianfeng Pan, Nan Zhou

Pageof 2

Frequent Collaborators

4 joint publications

Xiaowei Liu

3 joint publications

Yu Peng

2 joint publications

Jianfeng Pan

2 joint publications

Ziheng Peng